Myazi 250mg 6 Tablets

Babies: Not applicable. Lactating mother: Myazi tablet is safe to use in breastfeeding.
Human studies have shown that this drug not may pass into breast milk and does not harm the baby. But is a chance of causing diarrhoea or rash in the baby.
Pregnancy: Myazi tablet is safe to use in pregnancy. Animal studies have suggested that this drug may not have harmful effects on developing babies.
Alcohol: It is not safe to consume alcohol with an myazi tablet. Driving: It is safe to drive after taking this medication.
Kidney: Myazi tablets must be used with caution in patients with kidney disease. Dose adjustment is required.
Consult your doctor. Liver: Myazi tablet must be used with caution in patients with liver disease.
Dose adjustment is required. Consult your doctor..

Nausea Vomiting Abdominal pain Diarrhea.

Myazi is an antibiotic (macrolide). It works by blocking the protein synthesis, which is required for bacteria to perform their important functions.
Hence, it stops the growth of bacteria. .

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Myazi is used in the treatment of bacterial infections • It can be taken 1 hour before or 2 hours after food • Consult your doctor if you experienced allergic reactions like an itchy rash, swelling of the face, throat, or tongue, or breathing difficulties while taking this medication • Consult your doctor if notice blood in stools • Antacids should be taken before 3 hours or after taking myazi.

Contraindications: • Myazi + Bepridil: Concurrent use may result in an increased risk of qt- interval prolongation • Myazi + Cisapride: Concurrent use may result in an increased risk of qt- interval prolongation • Myazi + Ergotamine: Concurrent use may result in an increased risk of acute ergotism (nausea, vomiting, vasospastic ischemia) • Myazi + Terfenadine: Concurrent use may result in an increased risk of qt- interval prolongation Major: • Myazi + Acecainide: Concurrent use may result in an increased risk of cardiotoxicity • Myazi + Amiodarone: Concurrent use may result in an increased risk of cardiotoxicity • Myazi + Ceritinib: Concurrent use may result in an increased risk of qt-interval prolongation • Myazi + Ciprofloxacin: Concurrent use may result in an increased risk of qt interval prolongation.